Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan-Feb;56(1):43-7.
doi: 10.1590/S0036-46652014000100006.

In vitro antigiardial activity of the cysteine protease inhibitor E-64

Affiliations

In vitro antigiardial activity of the cysteine protease inhibitor E-64

Thaís Batista de Carvalho et al. Rev Inst Med Trop Sao Paulo. 2014 Jan-Feb.

Abstract

The quest for new antiparasitic alternatives has led researchers to base their studies on insights into biology, host-parasite interactions and pathogenesis. In this context, proteases and their inhibitors are focused, respectively, as druggable targets and new therapy alternatives. Herein, we proposed to evaluate the in vitro effect of the cysteine protease inhibitor E-64 on Giardia trophozoites growth, adherence and viability. Trophozoites (105) were exposed to E-64 at different final concentrations, for 24, 48 and 72 h at 37 °C. In the growth and adherence assays, the number of trophozoites was estimated microscopically in a haemocytometer, whereas cell viability was evaluated by a dye-reduction assay using MTT. The E-64 inhibitor showed effect on growth, adherence and viability of trophozoites, however, its better performance was detected in the 100 µM-treated cultures. Although metronidazole was more effective, the E-64 was shown to be able to inhibit growth, adherence and viability rates by ≥ 50%. These results reveal that E-64 can interfere in some crucial processes to the parasite survival and they open perspectives for future investigations in order to confirm the real antigiardial potential of the protease inhibitors.

As cisteína-proteases estão entre os alvos mais promissores para o desenvolvimento de novos agentes terapêuticos, visto que participam de eventos fundamentais do ciclo de vida de muitos microorganismos, inclusive Giardia. Como a atividade das proteases pode ser controlada por inibidores específicos, essas substâncias têm sido avaliadas quanto ao potencial antiparasitário. Diante disso, o presente estudo teve por objetivo avaliar o efeito in vitro do inibidor de cisteína-proteases E-64 sobre o crescimento, a aderência e a viabilidade de trofozoítos de cepa de Giardia isolada em Botucatu. Nos ensaios de crescimento e aderência, o número de trofozoítos foi estimado microscopicamente em hemocitômetro, enquanto que a viabilidade celular foi avaliada pelo método do MTT. No presente estudo, embora o metronidazol tenha se apresentado bastante efetivo, o E-64 mostrou ser capaz de inibir o crescimento, a aderência e a viabilidade em taxas superiores a 50%, especialmente nos cultivos expostos à concentração de 100 µM. A despeito de preliminares, esses resultados demonstram que o inibidor E-64 pode interferir em processos primordiais para a sobrevivência do parasita, além do que, abrem novas perspectivas para investigações futuras a fim de se avaliar o real potencial giardicida dos inibidores de proteases.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. In vitro effect of E-64 inhibitor (µM) on the growth of G. duodenalis trophozoites, after incubation for 24, 48 and 72 hours. Non-treated cultures (NTC) and metronidazole-treated cultures (MTZ) were included in all assays. Data expressed as means of trophozoites number (105) ± standard deviation (SD) in assays performed in triplicate.
Fig. 2
Fig. 2. In vitro effect of E-64 inhibitor (µM) on the adherence of G. duodenalis trophozoites, after incubation for 24 and 48 hours. Non-treated cultures (NTC) and metronidazole-treated cultures (MTZ) were included in all assays. Data expressed as means of attached trophozoites number (105) ± standard deviation (SD) in assays performed in triplicate.
Fig. 3
Fig. 3. Viability (MTT assay) of G. duodenalis after incubation with different concentrations of E-64 inhibitor (µM). Cultures treated with metronidazole (MTZ) at 40 µg/mL were included as control. The values correspond to mean ± standard deviation (SD) in assays performed in triplicate.

Similar articles

Cited by

References

    1. Adam RD. Biology of Giardia lamblia . Clin Microbiol Rev. 2001;14:447–475. - PMC - PubMed
    1. Barat LM, Bloland PB. Drug resistance among malaria and other parasites. Infect Dis Clin North Am. 1997;11:969–987. - PubMed
    1. Beynon RJ, Bond JS, editors . Proteolytic enzymes: a practical approach. Oxford: Oxford University Press; 1989.
    1. Carvalho TB, David EB, Coradi ST, Guimarães S. Protease activity in extracellular products secreted in vitro by trophozoites of Giardia duodenalis . Parasitol Res. 2008;104:185–190. - PubMed
    1. Coradi ST, Guimarães S. Giardia duodenalis: protein substrates degradation by trophozoite proteases. Parasitol Res. 2006;99:131–136. - PubMed

Publication types

MeSH terms